Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs--Georgia, 2018

Authors :: Stvilia, Ketevan
Spradling, Philip R.
Asatiani, Alexander
Gogia, Maka
Kutateladze, Khatuna
Butsashvili, Maia
Zarkua, Jaba
Tsertsvadze, Tengiz
Sharvadze, Lali
Japaridze, Maia
Kuchuloria, Tinatin
Gvinjilia, Lia
Tskhomelidze, Irinka
Gamkrelidze, Amiran
Khonelidze, Irma
Sergeenko, David
Shadaker, Shaun
Averhoff, Francisco
Nasrullah, Muazzam
Source :: Morbidity and Mortality Weekly Report. July 26, 2019, Vol. 68 Issue 29, p637, 5 p.
Publication Year :: 2019
Abstract: In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world's first [...]

Subjects :: Drugs -- Health aspects
Resveratrol -- Health aspects
Virus diseases -- Drug therapy -- Diagnosis -- Health aspects
Infection -- Drug therapy -- Diagnosis -- Health aspects
Hepatitis C virus -- Health aspects
Antibodies -- Health aspects
Biological products -- Health aspects
Syringes
Medical testing products
Health

Tools